US Organ Preservation Market Research Report By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage), By Organ Type (Kidney, Liver, Heart, Lungs) and By End User (Hospitals & Clinics, Organ Banks) - Forecast to 2035

US Organ Preservation Market Overview

As per MRFR analysis, the US Organ Preservation Market Size was estimated at 78.72 (USD Million) in 2023. The US Organ Preservation Market Industry is expected to grow from 85(USD Million) in 2024 to 158 (USD Million) by 2035. The US Organ Preservation Market CAGR (growth rate) is expected to be around 5.798% during the forecast period (2025 - 2035).

Key US Organ Preservation Market Trends Highlighted

The US Organ Preservation Market is experiencing significant trends driven by advancements in medical technology and increasing demand for organ transplantation. A key market driver is the rising prevalence of chronic diseases, which leads to a higher need for organ transplants. The aging population in the US further exacerbates this demand, as older individuals are more likely to require organ replacement due to organ failures. Additionally, regulatory support from institutions such as the US Department of Health and Human Services encourages research and development in organ preservation techniques, thereby promoting growth in the market.

Opportunities in the US Organ Preservation Market include the development of innovative preservation solutions that enhance organ viability and reduce transplantation failures.Improved methods such as normothermic machine perfusion and advanced cold storage techniques are being actively explored. These technologies not only promise better outcomes for transplant patients but also extend the preservation time for organs, making more efficient use of available organs. In recent times, there has been a notable trend toward using organ preservation techniques in multi-organ transplants, which can improve transplant success rates.

Furthermore, the ethical considerations around organ donation and transplantation are evolving, with increased public awareness leading to more individuals signing up for organ donation. Collaborative efforts between healthcare providers, non-profit organizations, and governmental bodies are essential for educating the public and promoting donor registrations.Overall, these trends signify a dynamic and responsive market in response to the urgent need for effective organ preservation solutions in the US.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Organ Preservation Market Drivers

Increasing Number of Organ Transplants

The growing number of organ transplants carried out each year is fueling development in the US organ preservation market. Over 39,000 organ transplants were carried out in the US in 2022, according to the United Network for Organ Sharing (UNOS), a figure that has steadily risen over the previous 10 years. An older population and improvements in medical technology are the main causes of this increase in transplant procedures. Given that 40% of receivers are 50 years of age or older, the need for organ preservation technologies is expected to rise as the population ages.

The US organ preservation market industry is indirectly boosted by organizations like the National Institutes of Health (NIH), which have played a key role in research projects aimed at increasing organ transplant success rates.

Technological Advancements in Preservation Methods

The US Organ Preservation Market Industry is benefitting from significant technological advancements in organ preservation methods. Innovative solutions such as Machine Perfusion, which helps maintain organ function during transportation, are gaining traction. The American Society of Transplant Surgeons (ASTS) reports that machine perfusion can enhance organ viability and improve transplant outcomes, particularly for kidneys and livers. As a result, hospitals and transplant centers are increasingly adopting these technologies, leading to a corresponding rise in the demand for organ preservation products and services.

Growing Public Awareness and Donation Drives

Public awareness about the importance of organ donation has spurred a significant increase in donor registrations across the United States. According to data from the Health Resources and Services Administration (HRSA), the national organ donor registry saw a surge of over 12 million new registrants in 2021 alone. Campaigns and initiatives led by organizations such as Donate Life America have effectively educated the public about organ donation's life-saving potential, which translates into a higher volume of organs available for transplantation and, subsequently, a greater need for effective organ preservation techniques in the US Organ Preservation Market Industry.

Regulatory Support for Organ Preservation Initiatives

Regulatory measures and incentives promoting organ donation and preservation are contributing positively to the US Organ Preservation Market Industry. The recent Advancing American Kidney Health initiative introduced by the U.S. Department of Health and Human Services aims to increase the number of kidney transplants and improve preservation techniques. This government-sponsored program can be seen as a response to the growing waitlist for organ transplants in the U.S.Census Bureau indicates that about 100,000 individuals are currently on the transplant waiting list. By prioritizing organ preservation and enhancing the infrastructure around organ donation, these regulatory frameworks are fostering an environment ripe for market growth.

US Organ Preservation Market Segment Insights

Organ Preservation Market Solution Insights

The US Organ Preservation Market has been experiencing substantial growth, particularly within the Solution segment, which is pivotal in enhancing the viability of organs for transplantation. This segment plays a critical role in ensuring that organs remain functional during the transportation process, significantly impacting transplant outcomes. Among the various solutions utilized, the University of Wisconsin Solution is acclaimed for its efficacy in preserving kidneys and other solid organs, making it a preferred choice among medical professionals.

Another notable solution is Custodial HTK, which has been specifically designed to preserve organs by maintaining their physiological processes during the cold storage period. As a result, it is widely accepted for use in liver and heart transplants. Collins Solution is also significant, particularly for liver transplants, as it is formulated to provide optimal conditions for organ preservation, thus improving the survival rates post-transplant.

The Celsior Solution, known for its unique composition, offers considerable benefits to the preservation of pancreatic and renal tissues, facilitating better outcomes in transplantation procedures. Perfadex is a specialized solution primarily for lung preservation, which has gained prominence due to its effectiveness in prolonging the organ's functional state. Citrate Solution is primarily used in vascular graft preservation, playing a crucial role in maintaining the longevity of these critical tissues.

Current trends indicate that the choice of preservation solution can significantly influence the efficiency of organ transplant operations and, consequently, the overall patient survival rates. The growth drivers for this market segment include an increasing number of organ transplant procedures and advancements in preservation technologies, which provide opportunities for innovation and market expansion. Additionally, as the US healthcare system increasingly focuses on improving transplant success rates, the demand for robust preservation solutions remains strong, illustrating the importance of this segment in the larger context of the US Organ Preservation Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Organ Preservation Market Preservation Techniques Insights

The Preservation Techniques segment within the US Organ Preservation Market plays a critical role in ensuring the viability of organs for transplantation. This segment primarily includes Static Cold Storage and Dynamic Cold Storage, both of which are essential methods used to extend the life of harvested organs. Static Cold Storage is a widely adopted technique that offers simplicity and cost-effectiveness, making it a popular choice among hospitals.

On the other hand, Dynamic Cold Storage is gaining traction due to its ability to optimize organ function during preservation, thereby enhancing transplantation success rates.The increasing number of organ transplant surgeries, driven by rising incidences of organ failure in the US, underscores the importance of effective preservation techniques. Furthermore, advancements in technology are creating opportunities for improved storage solutions that can enhance organ preservation and reduce wastage, thereby illustrating the market's growth potential. Overall, these preservation techniques are crucial in improving patient outcomes and increasing the efficiency of organ transplant processes in the US.

Organ Preservation Market Organ Type Insights

The US Organ Preservation Market exhibits considerable segmentation by organ type, encompassing critical categories such as Kidney, Liver, Heart, and Lungs. This market is pivotal to enhancing transplant success rates and improving patient outcomes. The Kidney segment holds a significant position, largely due to the high demand for kidney transplants resulting from chronic kidney diseases, making it a crucial focus for preservation efforts.

The Liver segment is similarly vital, as liver diseases remain prevalent and necessitate effective preservation techniques to facilitate successful transplants, thus highlighting its importance within the market.The Heart segment benefits from advances in preservation technology aimed at extending the viability of donor hearts, addressing the growing need for cardiac transplants amid increasing cardiovascular diseases in the US population.

Lastly, the Lungs segment accounts for a smaller portion of the market but faces unique challenges, primarily linked to the organ's sensitivity to time and condition during preservation, emphasizing the need for specialized solutions. Collectively, these segments illustrate the diversity and complexity of the US Organ Preservation Market, with significant emphasis placed on improving methodologies to enhance the quality of life for patients in need of organ transplants.

Organ Preservation Market End User Insights

The End User segment of the US Organ Preservation Market plays a critical role in the overall infrastructure for organ transplantation. This segment comprises primary stakeholders like Hospitals and Clinics, along with Organ Banks, which are essential for maintaining the integrity and viability of organs for transplantation. Hospitals and Clinics are pivotal as they provide the necessary facilities and specialized healthcare professionals required for organ preservation, ensuring that organs are preserved under optimal conditions before transplantation.

Organ Banks, on the other hand, function as collection and storage facilities for donated organs, acting as a central hub in the transplantation process. They are responsible for the evaluation, preservation, and allocation of organs, which is crucial given the pressing need for organ donations in the US. The increasing number of organ transplant procedures coupled with advancements in preservation technologies drives the demand in this segment. However, this market also faces challenges, such as logistical issues and regulatory guidelines that can impact the effectiveness of organ preservation.Overall, this market segment is vital in addressing the healthcare needs of patients requiring organ transplants while also offering opportunities for innovation in preservation methods and technologies.

US Organ Preservation Market Key Players and Competitive Insights

The US Organ Preservation Market has seen significant advancements and a competitive edge driven by technological innovation, improved processes, and strategic collaborations. As the demand for organ transplants continues to rise, various players in the market are focusing on enhancing preservation methods to prolong organ viability outside the human body. Research and development efforts have concentrated on developing novel preservation solutions and devices, driving the market forward with solutions that enhance preservation times and overall organ function post-transplant. Additionally, regulatory frameworks and partnerships with transplant centers play a crucial role in shaping the competitive landscape. Companies are continually looking to gain an edge through differentiation in their product offerings and exploring mergers and acquisitions to strengthen their market position.

Lifeline Scientific has established a notable presence in the US Organ Preservation Market with a strong focus on innovative organ preservation technologies. The company's strengths lie in its state-of-the-art preservation solutions that significantly enhance organ viability, ensuring better outcomes in transplantation. Lifeline Scientific is known for its proprietary systems that enable optimal organ preservation by minimizing ischemia and maximizing the quality of donated organs. The company's commitment to research and development has solidified its reputation as a key player in the market, allowing it to maintain a competitive advantage. Moreover, Lifeline Scientific has developed strategic partnerships with transplant centers, which helps in the adoption of its innovative technologies across the healthcare landscape in the US.

Bellicum Pharmaceuticals, while primarily known for its advancements in cell therapy treatments, also holds a considerable stake in the US Organ Preservation Market. The company offers unique technologies aimed at improving organ preservation through genetically engineered cell therapies that enhance the viability of transplanted organs. Bellicum's strengths include its focus on innovation and ongoing clinical trials that reinforce its commitment to expanding its product portfolio in the organ preservation space. The company's active engagement in mergers and acquisitions has allowed it to integrate complementary technologies into its offerings, thereby bolstering its presence in the US market. This strategic positioning enables Bellicum Pharmaceuticals to leverage its scientific expertise to address the significant challenges associated with organ preservation and create solutions that cater specifically to the needs of the transplant community.

Key Companies in the US Organ Preservation Market Include

• Lifeline Scientific


• Bellicum Pharmaceuticals


• Celsior


• TransMedics


• Otsuka Pharmaceutical


• Acelity


• Vitrolife


• Bridge to Life


• ALung Technologies


• Advanced Biohealing


• Elekta


• Xvivo Perfusion


• VentriPoint Diagnostics


• Nateron


• Organ Recovery Systems

US Organ Preservation Market Industry Developments

The US Organ Preservation Market has seen significant developments in recent months, with companies like Lifeline Scientific and TransMedics advancing their preservation technologies. In August 2023, Lifeline Scientific announced an expansion in its operations, enhancing its capabilities in organ storage solutions, thus promoting better organ viability for transplantation. Meanwhile, in July 2023, TransMedics received FDA approval for its Organ Care System, which has been pivotal in improving organ preservation for heart transplants.

The market is also witnessing competitive growth, with market valuations of companies such as Otsuka Pharmaceutical and Celsior continuing to rise as they further innovate preservation techniques. In terms of mergers and acquisitions, there have been notable activities; for instance, in September 2022, Acelity announced the acquisition of Advanced Biohealing, which has shown promise in enhancing organ preservation methods. The ongoing advancements and competitive acquisitions are reshaping the landscape of organ preservation in the US, indicating a robust market that is evolving to increase the number of successful transplants. Moreover, the importance of bioengineering and perfusion technologies is increasingly gaining attention, reflecting the market's dynamic and growth-oriented nature.

US Organ Preservation Market Segmentation Insights

Organ Preservation Market Solution Outlook

• University of Wisconsin Solution


• Custodial HTK


• Collins Solution


• Celsior Solution


• Perfadex


• Citrate Solution

Organ Preservation Market Preservation Techniques Outlook

• Static Cold Storage


• Dynamic Cold Storage

Organ Preservation Market Organ Type Outlook

• Kidney


• Liver


• Heart


• Lungs

Organ Preservation Market End User Outlook

• Hospitals & Clinics


• Organ Banks

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	78.72(USD Million)
MARKET SIZE 2024	85.0(USD Million)
MARKET SIZE 2035	158.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.798% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Lifeline Scientific, Bellicum Pharmaceuticals, Celsior, TransMedics, Otsuka Pharmaceutical, Acelity, Vitrolife, Bridge to Life, ALung Technologies, Advanced Biohealing, Elekta, Xvivo Perfusion, VentriPoint Diagnostics, Nateron, Organ Recovery Systems
SEGMENTS COVERED	Solution, Preservation Techniques, Organ Type, End User
KEY MARKET OPPORTUNITIES	Innovative preservation technologies, Increased demand for organ transplants, Expansion of preservation for diverse organs, Enhanced perfusion solutions development, Collaborative research and partnerships
KEY MARKET DYNAMICS	Increasing organ transplantation demand, Advancements in preservation technologies, Regulatory support and policies, Rising awareness among healthcare providers, Growing investment in biotech research
COUNTRIES COVERED	US